Microbiological end-point determination of antibiotics

Microbial Ecology in Health and Disease

Volumn 10, Issue 1, 1998, Pages 3-11

  Rumney, C J ^a   Coutts, J T ^a   Smith, J S ^a   Rowland, I R ^a,b  

^a BIBRA INTERNATIONAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Antibiotic residues; EU regulations; Gut microflora; Spiramycin; Tilmicosin

Indexed keywords

EID: 0003323491     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.3402/mehd.v10i1.7819     Document Type: Article

References (29)

1. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrobial Agents and Chemotherapy 1994; 38: 409-14.
2. Van der Waaij D. Colonization resistance of the digestive tract. The germ-free animal in biomedical research. In Coates ME, Gustafsson BE, eds. Laboratory Animals Ltd, London: 1984: 155-65.
3. Gorbach SL. Perturbation of intestinal microflora. Vet Hum Toxicol 1993; 35 (Suppl. 1): 15-23.
4. Nord CE. The effect of antimicrobial agents on the ecology of the human intestinal microflora. Vet Microbiol 1993; 35: 193-7.
5. Council Regulation (EEC) No.2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in food stuffs of animal origin. Official Journal of the European Communities 1990; 33 (L224).
6. Corpet DE. Current status of models for testing antibiotic residues. Vet Hum Toxicol 1993; 35 (Suppl 1): 37-46.
7. Corpet DE. An evaluation of methods to assess the effect of antimicrobial residues on the human gut flora. Vet Microbiol 1993; 35: 199-212.
8. Rumney CJ, Rowland IR. Microbiological endpoint testing for veterinary antimicrobials-setting MRLs. Food and Chemical Toxicology 1995; 33: 331-3.
9. Boisseau J. The regulatory view point. J Vet Med 1989; 42: 58-63.
10. Raibaud P, Ducluzeau R, Dubos F, Hudault S, Bewa H, Muller MC. Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice. Am J Clin Nutrition 1980; 33: 2440-7.
11. Hazenberg MP, Bakker M, Verschoor-Burggraaf A. Effects of the human intestinal flora in germ-free mice. J Appl Bacteriol 1981; 50: 95-106.
12. Mallett AK, Bearne CA, Rowland IR, Farthing MJG, Cole CB, Fuller R. The use of rats associated with a human faecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol 1987; 63: 39-45.
13. Corpet DE. Microbial ecology of the intestine. In vitro, in vivo and mathematical models. Reviews in Science Technology 1989; 8: 391-403.
14. Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Critical Review in Food Science and Nutrition 1992; 31: 299-331.
15. Hirayama K, Itoh K, Takahashi E, Mitsuoka T. Comparison of composition of faecal microbiota and metabolism of faecal bacteria among 'human-flora-associated' mice inoculated with faeces from six different human donors. Microbial Ecology in Health and Disease 1995; 8: 199-211.
16. Ducluzeau R, Ladire M, Raibaud P. Effect of bran ingestion on the microbial faecal floras of human donors and of recipient gnotobiotic mice, and on the barrier effects exerted by these floras against various potentially pathogenic microbial strains. Ann Microbiol 1984; 135A: 303-18.
17. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 1993; 74: 667-74.
18. Rumney CJ, Rowland IR, Coutts TM, et al. Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis 1993; 14: 79-84.
19. Rumney CJ, Rowland IR, Saito Y, Hirahara T. Endogenous generation of N-nitroso compounds by human gut microorganisms and the influence of soybean oligosaccharides. Microbial Ecology in Health and Disease 1994; 7: 52.
20. Andremont A, Raibaud P, Tancrede C. Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human faecal flora. J Infect Dis 1983; 148: 579-87.
21. Pecquet S, Andremont A, Tancrede C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrobial Agents and Chemotherapy 1986; 29: 1047-52.
22. Corpet DE. Antibiotic residues and drug resistance in human intestinal flora. Antimicrobial Agents and Chemotherapy 1987; 31: 587-93.
23. Welling GW, Groen G, Tuinte JHM, Koopman JP, Kennis HM. Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria. Journal of General Microbiology 1980; 117: 57-63.
24. O'Rourke J, Lee A, McNeill J. Differences in the gastrointestinal microbiota of specific pathogen free mice: an often unknown variable in biomedical research. Lab Anim 1988; 22: 297-303.
25. Commission of the European Communities, October 1991, Establishment by the European Community of maximum residue limits (MRLs) for residues of veterinary medicinal products in foodstuffs of animal origin. The rules governing medicinal products in the European Community, Volume VI, p.92.
26. Thirty-eighth report of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Evaluation of certain veterinary drug residues in food. WHO Technical Report Series 1991; 815: 31-36.
27. Andremont A, Tancrede C, Desnottes J-F. Effect of oral spiramycin on the faecal and oral bacteria in human volunteers. J Antimicrob Chemother 1991; 27: 355-60.
28. Nouws JFM, Kuiper H, van Klingeren B, Kruyswijk PG. Establishment of a microbiologically acceptable daily intake of antimicrobial drug residues. Vet Q 1994; 16: 152-6.
29. Midtvedt T. Effects of antimicrobial agents upon the functional part of the intestinal flora. Scand J Infect Dis 1986; Suppl 49: 85-8.